Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. Bardia A, Pistilli B, Rugo H. J Clin Oncol 2025 Mar 28:JCO2402833. doi: 10.1200/JCO-24-02833.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bardia A, Pistilli B, Rugo H. Reply to: Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. J Clin Oncol 2025 Mar 28:JCO2402833. doi: 10.1200/JCO-24-02833.
PMID: 40153734